127 related articles for article (PubMed ID: 31932416)
1. Temporal Trends in Population-Level Cure of Cancer: The Australian Context.
Kou K; Dasgupta P; Cramb SM; Yu XQ; Baade PD
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):625-635. PubMed ID: 31932416
[TBL] [Abstract][Full Text] [Related]
2. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
AIRTUM Working Group
Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
4. Cancer cure for 32 cancer types: results from the EUROCARE-5 study.
Dal Maso L; Panato C; Tavilla A; Guzzinati S; Serraino D; Mallone S; Botta L; Boussari O; Capocaccia R; Colonna M; Crocetti E; Dumas A; Dyba T; Franceschi S; Gatta G; Gigli A; Giusti F; Jooste V; Minicozzi P; Neamtiu L; Romain G; Zorzi M; De Angelis R; Francisci S;
Int J Epidemiol; 2020 Oct; 49(5):1517-1525. PubMed ID: 32984907
[TBL] [Abstract][Full Text] [Related]
5. Proportion cured models applied to 23 cancer sites in Norway.
Cvancarova M; Aagnes B; Fosså SD; Lambert PC; Møller B; Bray F
Int J Cancer; 2013 Apr; 132(7):1700-10. PubMed ID: 22927104
[TBL] [Abstract][Full Text] [Related]
6. Temporal changes in loss of life expectancy due to cancer in Australia: a flexible parametric approach.
Baade PD; Youlden DR; Andersson TM; Youl PH; Walpole ET; Kimlin MG; Aitken JF; Biggar RJ
Cancer Causes Control; 2016 Aug; 27(8):955-64. PubMed ID: 27306518
[TBL] [Abstract][Full Text] [Related]
7. Temporal trends in loss of life expectancy after a cancer diagnosis among the Australian population.
Kou K; Dasgupta P; Cramb SM; Yu XQ; Andersson TM; Baade PD
Cancer Epidemiol; 2020 Apr; 65():101686. PubMed ID: 32062407
[TBL] [Abstract][Full Text] [Related]
8. The relative survival and cure fraction of gastric cancer estimated through flexible parametric models using data from population-based cancer registration during 2003-2012 in Linzhou, China.
Chen Q; Liu SZ; Zhang SK; Cao XQ; Li BY; Quan PL; Guo LW; Dong L; Sun XB; Zhang Y; Zhang JG
Cancer Med; 2020 Mar; 9(6):2243-2251. PubMed ID: 31994324
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
10. Excess risk of dying of other causes of cured cancer patients.
Botta L; Gatta G; Trama A; Capocaccia R
Tumori; 2019 Jun; 105(3):199-204. PubMed ID: 30905274
[TBL] [Abstract][Full Text] [Related]
11. Prognosis and cure of long-term cancer survivors: A population-based estimation.
Dal Maso L; Panato C; Guzzinati S; Serraino D; Francisci S; Botta L; Capocaccia R; Tavilla A; Gigli A; Crocetti E; Rugge M; Tagliabue G; Filiberti RA; Carrozzi G; Michiara M; Ferretti S; Cesaraccio R; Tumino R; Falcini F; Stracci F; Torrisi A; Mazzoleni G; Fusco M; Rosso S; Tisano F; Fanetti AC; Sini GM; Buzzoni C; De Angelis R;
Cancer Med; 2019 Aug; 8(9):4497-4507. PubMed ID: 31207165
[TBL] [Abstract][Full Text] [Related]
12. Does minimum follow-up time post-diagnosis matter? An assessment of changing loss of life expectancy for people with cancer in Western Australia from 1982 to 2016.
Wright CM; Moorin RE
Cancer Epidemiol; 2020 Jun; 66():101705. PubMed ID: 32224327
[TBL] [Abstract][Full Text] [Related]
13. Cure of cancer for seven cancer sites in the Flemish Region.
Silversmit G; Jegou D; Vaes E; Van Hoof E; Goetghebeur E; Van Eycken L
Int J Cancer; 2017 Mar; 140(5):1102-1110. PubMed ID: 27870056
[TBL] [Abstract][Full Text] [Related]
14. Quantifying the Number of Cancer Deaths Avoided Due to Improvements in Cancer Survival since the 1980s in the Australian Population, 1985-2014.
Dasgupta P; Cramb SM; Kou K; Yu XQ; Baade PD
Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1825-1831. PubMed ID: 32699079
[TBL] [Abstract][Full Text] [Related]
15. The cure of cancer: a European perspective.
Francisci S; Capocaccia R; Grande E; Santaquilani M; Simonetti A; Allemani C; Gatta G; Sant M; Zigon G; Bray F; Janssen-Heijnen M;
Eur J Cancer; 2009 Apr; 45(6):1067-79. PubMed ID: 19131242
[TBL] [Abstract][Full Text] [Related]
16. Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models.
Andersson TM; Dickman PW; Eloranta S; Lambert PC
BMC Med Res Methodol; 2011 Jun; 11():96. PubMed ID: 21696598
[TBL] [Abstract][Full Text] [Related]
17. Estimating the proportion cured of cancer: some practical advice for users.
Yu XQ; De Angelis R; Andersson TM; Lambert PC; O'Connell DL; Dickman PW
Cancer Epidemiol; 2013 Dec; 37(6):836-42. PubMed ID: 24042025
[TBL] [Abstract][Full Text] [Related]
18. Major patterns of cancer cure: Clinical implications.
Tralongo P; Surbone A; Serraino D; Dal Maso L
Eur J Cancer Care (Engl); 2019 Nov; 28(6):e13139. PubMed ID: 31436897
[TBL] [Abstract][Full Text] [Related]
19. Temporal trends in the proportion cured among adults diagnosed with acute myeloid leukaemia in Sweden 1973-2001, a population-based study.
Andersson TM; Lambert PC; Derolf AR; Kristinsson SY; Eloranta S; Landgren O; Björkholm M; Dickman PW
Br J Haematol; 2010 Mar; 148(6):918-24. PubMed ID: 19995394
[TBL] [Abstract][Full Text] [Related]
20. Temporal trends in the risk of second primary cancers among survivors of adult-onset cancers, 1980 through 2013: An Australian population-based study.
Ye Y; Otahal P; Wills KE; Neil AL; Venn AJ
Cancer; 2018 Apr; 124(8):1808-1818. PubMed ID: 29370456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
